Observational studyKorean journal of urology2015
Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men.
Farid Saad et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papertrialcites it